These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas. Chasseloup F; Regazzo D; Tosca L; Proust A; Kuhn E; Hage M; Jublanc C; Mokhtari K; Dalle Nogare M; Avallone S; Ceccato F; Tachdjian G; Salenave S; Young J; Gaillard S; Parker F; Boch AL; Chanson P; Bouligand J; Occhi G; Kamenický P Eur J Endocrinol; 2024 Feb; 190(2):173-181. PubMed ID: 38330165 [TBL] [Abstract][Full Text] [Related]
27. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells. Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434 [TBL] [Abstract][Full Text] [Related]
28. FTO-mediated DSP m Zou Y; Bao X; Li D; Ye Z; Xiang R; Yang Y; Zhu Z; Chen Z; Zeng L; Xue C; Zhao H; Yao B; Zhang Q; Yan Z; Deng Z; Cheng J; Yue G; Hu W; Zhao J; Bai R; Zhang Z; Liu A; Zhang J; Zuo Z; Jiang X Mol Cancer; 2024 Sep; 23(1):205. PubMed ID: 39304899 [TBL] [Abstract][Full Text] [Related]
29. Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas. Tang Y; Xie T; Wu S; Yang Q; Liu T; Li C; Liu S; Shao Z; Zhang X Endocrine; 2021 Nov; 74(2):375-386. PubMed ID: 34043183 [TBL] [Abstract][Full Text] [Related]
30. Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors. Herrgott GA; Asmaro KP; Wells M; Sabedot TS; Malta TM; Mosella MS; Nelson K; Scarpace L; Barnholtz-Sloan JS; Sloan AE; Selman WR; deCarvalho AC; Poisson LM; Mukherjee A; Robin AM; Lee IY; Snyder J; Walbert T; Rosenblum M; Mikkelsen T; Bhan A; Craig J; Kalkanis S; Rock J; Noushmehr H; Castro AV Neuro Oncol; 2022 Jul; 24(7):1126-1139. PubMed ID: 35212383 [TBL] [Abstract][Full Text] [Related]
31. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1. Asa SL; Mete O; Riddle ND; Perry A Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858 [TBL] [Abstract][Full Text] [Related]
32. Lysine Methyltransferase 5A Promotes the Progression of Growth Hormone Pituitary Neuroendocrine Tumors through the Wnt/β-Catenin Signaling Pathway. Li J; Song H; Chen T; Zhang S; Zhang C; Ma C; Zhang L; Wang T; Qian Y; Deng X Neuroendocrinology; 2024; 114(6):589-601. PubMed ID: 38565081 [TBL] [Abstract][Full Text] [Related]
33. Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors. Cui Y; Li C; Jiang Z; Zhang S; Li Q; Liu X; Zhou Y; Li R; Wei L; Li L; Zhang Q; Wen L; Tang F; Zhou D Neuro Oncol; 2021 Nov; 23(11):1859-1871. PubMed ID: 33908609 [TBL] [Abstract][Full Text] [Related]
34. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro. Kontogeorgos G; Asa SL; Kovacs K; Smyth HS; Singer W Acta Endocrinol (Copenh); 1993 Dec; 129(6):565-72. PubMed ID: 7509101 [TBL] [Abstract][Full Text] [Related]
35. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease. Rak B; Maksymowicz M; Pękul M; Zieliński G Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861 [TBL] [Abstract][Full Text] [Related]
36. Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors. Wang L; Wei C; Wang Y; Huang N; Zhang T; Dai Y; Xue L; Lin S; Wu ZB Front Endocrinol (Lausanne); 2023; 14():1149997. PubMed ID: 37534217 [TBL] [Abstract][Full Text] [Related]
37. The Integrated Stress Response Is Tumorigenic and Constitutes a Therapeutic Liability in Somatotroph Adenomas. Li Z; Chen Y; Yao X; Liu Q; Zhu H; Zhang Y; Feng J; Gao H Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361871 [TBL] [Abstract][Full Text] [Related]
38. The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes. Salomon MP; Wang X; Marzese DM; Hsu SC; Nelson N; Zhang X; Matsuba C; Takasumi Y; Ballesteros-Merino C; Fox BA; Barkhoudarian G; Kelly DF; Hoon DSB Clin Cancer Res; 2018 Sep; 24(17):4126-4136. PubMed ID: 30084836 [No Abstract] [Full Text] [Related]
39. [Neuroimaging of Pituitary Neuroendocrine Tumors]. Kurosaki M No Shinkei Geka; 2023 Jul; 51(4):634-641. PubMed ID: 37491060 [TBL] [Abstract][Full Text] [Related]
40. Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern. Kim K; Kim Y; Kim SH; Moon JH; Kim EH; Lee EJ; Oh CM; Ku CR Front Oncol; 2024; 14():1423606. PubMed ID: 39139281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]